The Continuing High Cost of Insulin
Insulin’s high cost remains a problem: In a study of nearly 200 people with diabetes who were prescribed insulin, a quarter reported either using less insulin than prescribed or not filling the prescription due to cost. Those individuals had higher average glucose levels. But there may be a solution for some people. In a second study of over 50,000 participants with type 2 diabetes, researchers found no difference in rates of emergency room visits or hospitalizations related to low blood glucose levels between those taking the older, less-expensive NPH insulin versus the newer (and more-expensive) analogs glargine (Lantus) and detemir (Levemir). If you have type 2 diabetes and are having trouble affording insulin, talk to your doctor about whether a switch to NPH insulin may help. There’s another way to save money on meds if you have type 1 or if NPH isn’t a good fit for you: Call your insulin manufacturer and ask about prescription assistance programs; most offer such programs to help lower medication costs.
Source: The American Diabetes Association 78th annual Scientific Sessions.